| RS2148389772 |
ABCD1
|
Health Risk |
Pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS2148389834 |
ABCD1
|
Health Risk |
Pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS2148389850 |
ABCD1
|
Health Risk |
Pathogenic |
— |
| RS2148389899 |
ABCD1
|
Health Risk |
Pathogenic |
— |
| RS2148389929 |
ABCD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS2148389975 |
ABCD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS2148389994 |
ABCD1
|
Health Risk |
Pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS2148390396 |
YRDC
|
Health Risk |
Pathogenic |
Galloway-Mowat syndrome 10, Galloway-Mowat syndrome 10 |
| RS2148391889 |
ABCD1
|
Health Risk |
Likely pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS2148391907 |
ABCD1
|
Health Risk |
Pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS2148391908 |
ABCD1
|
Health Risk |
Pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS2148391915 |
ABCD1
|
Health Risk |
Likely pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS2148391974 |
ABCD1
|
Health Risk |
Pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS2148393387 |
MYT1L
|
Health Risk |
Likely pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS2148395370 |
ABCD1
|
Health Risk |
Likely pathogenic |
Abnormality of the nervous system, Abnormality of the nervous system |
| RS2148395507 |
ABCD1
|
Health Risk |
Pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS2148395658 |
ABCD1
|
Health Risk |
Pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS2148396057 |
ABCD1
|
Health Risk |
Pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS2148396070 |
ABCD1
|
Health Risk |
Likely pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS2148397523 |
ABCD1
|
Health Risk |
Pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS2148397528 |
KIDINS220
|
Health Risk |
Pathogenic |
Ventriculomegaly and arthrogryposis, Ventriculomegaly and arthrogryposis |
| RS2148397545 |
ABCD1
|
Health Risk |
Pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS2148397558 |
ABCD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS2148397565 |
ABCD1
|
Health Risk |
Likely pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS2148397619 |
ABCD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2148397899 |
ABCD1
|
Health Risk |
Pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS2148397922 |
ABCD1
|
Health Risk |
Pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS2148397936 |
ABCD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS2148397954 |
ABCD1
|
Health Risk |
Pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS2148398002 |
ABCD1;PLXNB3-AS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS2148398982 |
ABCD1
|
Health Risk |
Pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS2148398995 |
ABCD1
|
Health Risk |
Pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS2148399015 |
ABCD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS2148399029 |
ABCD1
|
Health Risk |
Pathogenic |
Primary adrenocortical insufficiency, Primary adrenocortical insufficiency |
| RS2148399034 |
ABCD1
|
Health Risk |
Pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS2148399060 |
ABCD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS2148399201 |
ABCD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS2148399204 |
ABCD1;PLXNB3-AS1
|
Health Risk |
Likely pathogenic |
— |
| RS2148399208 |
ABCD1
|
Health Risk |
Likely pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS2148399209 |
ABCD1
|
Health Risk |
Pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS2148399303 |
ABCD1
|
Health Risk |
Pathogenic |
— |
| RS2148399307 |
ABCD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Adrenoleukodystrophy, ABCD1-related disorder |
| RS2148399308 |
ABCD1
|
Health Risk |
Likely pathogenic |
— |
| RS2148399327 |
ABCD1
|
Health Risk |
Pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS2148399330 |
ABCD1
|
Health Risk |
Pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS2148399483 |
ABCD1
|
Health Risk |
Pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS2148401189 |
MACF1
|
Health Risk |
Likely pathogenic |
Lissencephaly 9 with complex brainstem malformation, Lissencephaly 9 with complex brainstem malformation |
| RS2148409694 |
CHRDL1
|
Health Risk |
Pathogenic |
Megalocornea, Megalocornea |
| RS2148409748 |
CHRDL1
|
Health Risk |
Pathogenic |
Megalocornea, Megalocornea |
| RS2148410077 |
NBAS
|
Health Risk |
Likely pathogenic |
— |
| RS2148412722 |
ADGRG1
|
Health Risk |
Pathogenic |
— |
| RS2148414753 |
PCARE
|
Health Risk |
Pathogenic |
— |
| RS2148414919 |
PCARE
|
Health Risk |
Pathogenic |
— |
| RS2148415202 |
PCARE
|
Health Risk |
Pathogenic |
— |
| RS2148415381 |
PCARE
|
Health Risk |
Pathogenic |
— |
| RS2148415455 |
PCARE
|
Health Risk |
Pathogenic |
— |
| RS2148415467 |
PCARE
|
Health Risk |
Pathogenic |
— |
| RS2148415628 |
PCARE
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 54, Retinitis pigmentosa 54 |
| RS2148415700 |
PCARE
|
Health Risk |
Pathogenic |
— |
| RS2148415744 |
PCARE
|
Health Risk |
Pathogenic |
— |
| RS2148416007 |
PCARE
|
Health Risk |
Pathogenic |
— |
| RS2148416150 |
PCARE
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 54, Retinitis pigmentosa 54 |
| RS2148416171 |
PCARE
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 54, Retinitis pigmentosa 54 |
| RS2148416373 |
PCARE
|
Health Risk |
Pathogenic |
— |
| RS2148416461 |
PCARE
|
Health Risk |
Pathogenic |
— |
| RS2148416488 |
PCARE
|
Health Risk |
Pathogenic |
— |
| RS2148416614 |
PCARE
|
Health Risk |
Pathogenic |
— |
| RS2148416620 |
PCARE
|
Health Risk |
Pathogenic |
— |
| RS2148416762 |
PCARE
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 54, Retinitis pigmentosa 54 |
| RS2148416787 |
PCARE
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2148416970 |
PCARE
|
Health Risk |
Pathogenic |
— |
| RS2148417003 |
CSF2RA
|
Health Risk |
Pathogenic |
Surfactant metabolism dysfunction, pulmonary |
| RS2148417048 |
HMGCL
|
Health Risk |
Pathogenic |
Deficiency of hydroxymethylglutaryl-CoA lyase, Deficiency of hydroxymethylglutaryl-CoA lyase |
| RS2148418008 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2148418069 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2148418171 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2148418538 |
CHRDL1
|
Health Risk |
Pathogenic |
Megalocornea, Megalocornea |
| RS2148418732 |
CHRDL1
|
Health Risk |
Likely pathogenic |
Isolated congenital megalocornea, Isolated congenital megalocornea |
| RS2148419158 |
HMGCL
|
Health Risk |
Pathogenic |
Deficiency of hydroxymethylglutaryl-CoA lyase, Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency |
| RS2148419170 |
HMGCL
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of hydroxymethylglutaryl-CoA lyase, Deficiency of hydroxymethylglutaryl-CoA lyase |
| RS2148419206 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2148419527 |
DMD
|
Health Risk |
Pathogenic |
Abnormality of the musculature, Abnormality of the musculature |
| RS2148419679 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2148419938 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2148419974 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2148420687 |
HMGCL
|
Health Risk |
Pathogenic |
Deficiency of hydroxymethylglutaryl-CoA lyase, Deficiency of hydroxymethylglutaryl-CoA lyase |
| RS2148421651 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2148421666 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2148421809 |
DMD
|
Health Risk |
Pathogenic/Likely pathogenic |
Becker muscular dystrophy, Duchenne muscular dystrophy |
| RS2148422111 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2148422718 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Becker muscular dystrophy |
| RS2148423120 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS2148423696 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Becker muscular dystrophy |
| RS2148424154 |
HMGCL
|
Health Risk |
Pathogenic |
Deficiency of hydroxymethylglutaryl-CoA lyase, Deficiency of hydroxymethylglutaryl-CoA lyase |
| RS2148424175 |
HMGCL
|
Health Risk |
Pathogenic |
Deficiency of hydroxymethylglutaryl-CoA lyase, Deficiency of hydroxymethylglutaryl-CoA lyase |
| RS2148425853 |
HMGCL
|
Health Risk |
Pathogenic |
Deficiency of hydroxymethylglutaryl-CoA lyase, Deficiency of hydroxymethylglutaryl-CoA lyase |
| RS2148426389 |
ADGRG1
|
Health Risk |
Pathogenic |
— |
| RS2148427081 |
DMD
|
Health Risk |
Likely pathogenic |
Becker muscular dystrophy, Becker muscular dystrophy |
| RS2148427138 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2148427870 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |